Published in Cancer Vaccine Week, March 8th, 2004
"According to a study from the United States, "Oncogenic Ras mediates its actions through activation of multiple downstream effector signaling cascades, which in turn regulate transcription factor activation and cause changes in gene expression."
"However, there exist striking cell type differences in effector pathways that are activated by Ras, in which effectors are sufficient or necessary to promote Ras oncogenesis, and in the gene targets of Ras transformation. Therefore, we evaluated the contribution of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Vaccine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.